2023
DOI: 10.3389/fphar.2023.1265289
|View full text |Cite
|
Sign up to set email alerts
|

Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity

Huaxia Xie,
Longfei Mao,
Gaolu Fan
et al.

Abstract: Based on the structure of the anti-HIV drug cabotegravir, we introduced 1,2,3-triazole groups with different substituents to obtain 19 cabotegravir derivatives and tested their activity against HepG2 cells. The proliferation of HepG2 cells was examined following treatment with derivatives. Most of the compounds demonstrated significant inhibitory effects, particularly compounds KJ-5 and KJ-12 with IC50 values of 4.29 ± 0.10 and 4.07 ± 0.09 μM, respectively. Furthermore, both compounds 5 and 12 significantly ca… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 19 publications
0
2
0
Order By: Relevance
“…Its high efficacy at low doses and the high satisfaction reported by individuals living with HIV make it a very promising drug for long-term treatment [60]. Interestingly, some triazole analogues of cabotegravir were recently synthesized and tested in vitro for their antitumor activity against non-small-cell lung cancer cells [61] and a hepatocellular carcinoma cell line [62]. These results, along with our findings, suggest that the potential of cabotegravir in melanoma therapy deserves organoids and/or in vivo investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Its high efficacy at low doses and the high satisfaction reported by individuals living with HIV make it a very promising drug for long-term treatment [60]. Interestingly, some triazole analogues of cabotegravir were recently synthesized and tested in vitro for their antitumor activity against non-small-cell lung cancer cells [61] and a hepatocellular carcinoma cell line [62]. These results, along with our findings, suggest that the potential of cabotegravir in melanoma therapy deserves organoids and/or in vivo investigations.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, both KJ-5 and KJ-12 were found to induce apoptosis via the mitochondrial pathway and inhibit the invasion and migration of cancer cells. [ 19 ]. By utilizing the structural features of the EGFR inhibitor erlotinib, compounds a1–a22 with erlotinib-1,2,3-triazole derivatives were obtained through click reactions [ 20 ].…”
Section: Introductionmentioning
confidence: 99%